新股消息 | 天星医疗拟港股上市 中国证监会要求补充说明主要股东上层投资人等情况

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has issued supplementary material requirements for Tianxing Medical, which is in the process of listing on the Hong Kong Stock Exchange, focusing on the company's major shareholders and compliance with regulations [1][2]. Group 1: Regulatory Requirements - CSRC requires Tianxing Medical to clarify the basic situation of "overseas enterprises" and "Hong Kong companies" among its major shareholders, including any legal restrictions on shareholding [2][3]. - The company must provide updates on the progress of state-owned shareholders fulfilling state-owned share identification and other state asset management procedures [3][4]. Group 2: Business Operations and Plans - Tianxing Medical is required to explain its specific business types, operational methods, and future plans in simple terms, including details about its AI rehabilitation products and whether it holds the necessary qualifications [3][5]. - The company must clarify its previous application for listing on the Shanghai Stock Exchange, the reasons for withdrawal, and whether it plans to continue pursuing A-share listing [3][4]. Group 3: Financial Performance - For the fiscal years 2022 to 2025 (up to May 31), Tianxing Medical reported revenues of approximately 147 million, 239 million, 327 million, and 111 million RMB respectively, with net profits of approximately 40.34 million, 57.11 million, 95.39 million, and 32.59 million RMB [5].